Zhao et al. 1 1. Zhao, Y. ∙ Sun, Y. ∙ Zhu, X. ... An engineered probiotic for diagnosis and mucosal healing in inflammatory bowel disease Cell Rep. 2026; 45 :118171 Full Text Full Text (PDF) Scopus (0) PubMed Google Scholar engineer a reactive oxygen species-responsive probiotic strain of Escherichia coli that senses intestinal inflammation and responds by locally delivering IL-22-Fc to promote epithelial repair, establishing an integrated sense-and-respond platform for inflammatory bowel disease diagnosis and mucosal healing.
No takes yet. Share an insight, caveat, or question.
Robertin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: